What is Ashland's life sciences — cost of revenue?

Ashland (ASH) reported life sciences — cost of revenue of $109M in Q1 2026.

How has Ashland's life sciences — cost of revenue changed year-over-year?

Ashland's life sciences — cost of revenue decreased by 6.8% year-over-year, from $117M to $109M.

What does life sciences — cost of revenue mean?

This represents the direct costs attributable to the production of goods or the delivery of services sold by the segment, including raw materials, labor, and manufacturing overhead. It is a key measure of operational efficiency and direct margin management. Monitoring this metric helps assess the impact of input price inflation and production productivity on profitability.

Ashland ASH Life Sciences — Cost Of Revenue

Other segment segments

Specialty Additives

$118M+11.3%

Personal Care And Household

$88M+7.3%

Intermediates And Solvents

$29M-21.6%

Similar metrics at other companies

STELife Sciences: — Cost of Revenue

$65.6M+7.7%

RVTYLife Sciences — Segment Cost of Revenue

$131.57M+10.3%

TMOLife Sciences Solutions — Cost of revenues

$1B+17.4%

ALife Sciences and Diagnostics Markets — Cost of revenue

$337M+9.1%

BIOLife Science — Cost of goods sold

$100.9M+0.7%

DCILife Sciences Segment — Cost of Sales

$49.2M+7.9%

Other financials

Income statement

See full

Revenue$482.0M+0.6%

Gross profit$147.0M0.0%

Operating income$39.0M-23.5%

Net income$16.0M-48.4%

EPS (diluted)$0.34-47.7%

Balance sheet

See full

Cash & equivalents$343.0M+104%

Total debt$1.5B-0.6%

Total equity$1.9B-27.1%

Total assets$4.5B-14.0%

Cash flow

See full

Operating cash flow$50.0M+456%

CapEx$17.0M-19.0%

Free cash flow$33.0M+375%

Valuation

See full

Market cap$2.93B-9.0%

Enterprise value$4.06B-10.6%

P/S1.6×0.0×

Profitability

See full

Gross margin30%-1.7pp

Operating margin-37.3%—

Net margin-40.8%-48.8pp

FCF margin13.6%+9.7pp

Returns & leverage

See full

Return on equity-33.4%-38.5pp

Debt / equity0.8×+0.2×

Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — cost of revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ashland's life sciences — cost of revenue?: Ashland (ASH) reported life sciences — cost of revenue of $109M in Q1 2026.
How has Ashland's life sciences — cost of revenue changed year-over-year?: Ashland's life sciences — cost of revenue decreased by 6.8% year-over-year, from $117M to $109M.
What does life sciences — cost of revenue mean?: This represents the direct costs attributable to the production of goods or the delivery of services sold by the segment, including raw materials, labor, and manufacturing overhead. It is a key measure of operational efficiency and direct margin management. Monitoring this metric helps assess the impact of input price inflation and production productivity on profitability.